申请人:Arizona Board of Regents acting on behalf of Arizona State University
公开号:US05409953A1
公开(公告)日:1995-04-25
New antineoplastic substances have been isolated, structurally elucidated and synthesized having a general structural formula of: ##STR1## wherein: R.sub.1 is OH or OCH.sub.3 ; R.sub.2 is H or OCH.sub.3 ; or R.sub.1 R.sub.2 is --OCH.sub.2 O--; R.sub.3 is H or OH; R.sub.4 is OH or OCH.sub.3. These substances have been denominated "combretastatin A-1, -A-2, -A-3, -B-1, -B-2, -B-3 and -B-4". Pharmaceutical preparation containing the substances and methods of treating a host inflicted with a neoplastic growth with the preparation is described.
新的抗肿瘤物质已被分离、结构阐明和合成,其具有以下一般结构式:##STR1## 其中:R.sub.1为OH或OCH.sub.3;R.sub.2为H或OCH.sub.3;或R.sub.1 R.sub.2为--OCH.sub.2 O--;R.sub.3为H或OH;R.sub.4为OH或OCH.sub.3。这些物质被命名为"combretaSTatin A-1,-A-2,-A-3,-B-1,-B-2,-B-3和-B-4"。描述了含有这些物质的制药制剂以及使用该制剂治疗患有肿瘤生长的宿主的方法。